Gene mutations leading to functional impairment or increased expression of DAT have been correlated with various pathological conditions, such as parkinsonism or attention deficit hyperactive disorder (ADHD) [1,2]. This evidence concerns the gene SLC6A3 and attention deficit-hyperactivity disorder.